Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Operating Leases (2019 - 2026)

Viking Therapeutics' (VKTX) quarterly Operating Leases came in at $3.9 million in Q2 2026, up 857.32% year-over-year from $410000.0 in Q2 2025, and up 1134.28% quarter-over-quarter from $318000.0 in Q3 2025.

Analysis

Viking Therapeutics (VKTX) Operating Leases (2019 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Operating Leases across 7 years of filings, most recently posting $3.9 million for Q2 2026.

  • In Q2 2026, Operating Leases rose 857.32% year-over-year to $3.9 million; the TTM figure through Jun 2026 stood at $3.9 million (up 857.32% YoY), while the FY2024 annual figure was $630000.0, down 32.69% from the prior year.
  • Operating Leases came in at $3.9 million for Q2 2026 at Viking Therapeutics, up from $318000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.9 million in Q2 2026 to a low of $318000.0 in Q3 2025.
  • Average Operating Leases over 5 years is $1.1 million, with a median of $977000.0 recorded in 2023.
  • Year-over-year, Operating Leases slumped 57.88% in 2025 and jumped 857.32% in 2026.
  • Over 5 years, Operating Leases stood at $1.3 million in 2022, then declined by 25.71% to $936000.0 in 2023, then slumped by 32.69% to $630000.0 in 2024, then tumbled by 49.52% to $318000.0 in 2025, then jumped by 1134.28% to $3.9 million in 2026.
  • Per Business Quant data, the three most recent Operating Leases figures were $3.9 million in Q2 2026, $318000.0 in Q3 2025, and $410000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.93 Mn
Sep 30, 2025 318,000.00
Jun 30, 2025 410,000.00
Mar 31, 2025 502,000.00
Dec 31, 2024 630,000.00
Sep 30, 2024 755,000.00
Jun 30, 2024 766,000.00
Mar 31, 2024 852,000.00
Dec 31, 2023 936,000.00
Sep 30, 2023 1.02 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.18 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 1.34 Mn
Jun 30, 2022 1.41 Mn
Mar 31, 2022 1.49 Mn
Dec 31, 2020 29,000.00
Sep 30, 2020 115,000.00
Jun 30, 2020 198,000.00
Mar 31, 2020 279,000.00
API Access

Viking Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=VKTX&period=max&api_key=YOUR_API_KEY